Combination With Tomatidine Improves the Potency of Posaconazole Against Trypanosoma cruzi

Azoles such as posaconazole (Posa) are highly potent against . However, when tested in chronic Chagas disease patients, a high rate of relapse after Posa treatment was observed. It appears that inhibition of cytochrome CYP51, the target of azoles, does not deliver sterile cure in monotherapy. Lookin...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in cellular and infection microbiology Vol. 11; p. 617917
Main Authors: Rocha-Hasler, Marianne, de Oliveira, Gabriel Melo, da Gama, Aline Nefertiti, Fiuza, Ludmila Ferreira de Almeida, Fesser, Anna Frieda, Cal, Monica, Rocchetti, Romina, Peres, Raiza Brandão, Guan, Xue Li, Kaiser, Marcel, Soeiro, Maria de Nazaré Correia, Mäser, Pascal
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 04-03-2021
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Azoles such as posaconazole (Posa) are highly potent against . However, when tested in chronic Chagas disease patients, a high rate of relapse after Posa treatment was observed. It appears that inhibition of cytochrome CYP51, the target of azoles, does not deliver sterile cure in monotherapy. Looking for suitable combination partners of azoles, we have selected a set of inhibitors of sterol and sphingolipid biosynthetic enzymes. A small-scale phenotypic screening was conducted against the proliferative forms of , extracellular epimastigotes and intracellular amastigotes. Against the intracellular, clinically relevant forms, four out of 15 tested compounds presented higher or equal activity as benznidazole (Bz), with EC values ≤2.2 μM. Ro48-8071, an inhibitor of lanosterol synthase (ERG7), and the steroidal alkaloid tomatidine (TH), an inhibitor of C-24 sterol methyltransferase (ERG6), exhibited the highest potency and selectivity indices (SI = 12 and 115, respectively). Both were directed to combinatory assays using fixed-ratio protocols with Posa, Bz, and fexinidazole. The combination of TH with Posa displayed a synergistic profile against amastigotes, with a mean ΣFICI value of 0.2. assays using an acute mouse model of infection demonstrated lack of antiparasitic activity of TH alone in doses ranging from 0.5 to 5 mg/kg. As observed , the best combo proportion was the ratio 3 TH:1 Posa. The combination of Posa at 1.25 mpk plus TH at 3.75 mpk displayed suppression of peak parasitemia of 80% and a survival rate of 60% in the acute infection model, as compared to 20% survival for Posa at 1.25 mpk alone and 40% for Posa at 10 mpk alone. These initial results indicate a potential for the combination of posaconazole with tomatidine against .
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
This article was submitted to Parasite and Host, a section of the journal Frontiers in Cellular and Infection Microbiology
Reviewed by: Gildardo Rivera, Instituto Politécnico Nacional (IPN), Mexico; Emmanuel Oluwadare Balogun, Ahmadu Bello University, Nigeria
Edited by: Ghulam Jeelani, The University of Tokyo, Japan
ISSN:2235-2988
2235-2988
DOI:10.3389/fcimb.2021.617917